Combination of recombinant cytokines fails to produce ex vivo expansion of human blood hematopoietic progenitor cells

Ann Hematol. 1992 May;64(5):217-20. doi: 10.1007/BF01738299.

Abstract

The concept of ex vivo expansion of the human progenitor cell population was tested in this study. In the presence of interleukin-3 and -6 we compared the abilities of various liquid culture conditions of human blood-derived hematopoietic progenitor cells to yield a suitable condition for the expansion of blood progenitor cells. Although the best result was obtained in the gastpermeable bag culture system, the enhancement effect (maximum of 3.8-fold for granulocyte/macrophage colony-forming units and 3.0-fold for erythroid burst-forming units) lasted for only a short period (less than 6 d). The results of this study are disappointing for clinical use, and attempts with currently available technology appear to be limited in their potential.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Brain Neoplasms / blood*
  • Cell Division / drug effects
  • Cells, Cultured
  • Child
  • Child, Preschool
  • Colony-Forming Units Assay
  • Cytokines / pharmacology*
  • Erythropoietin / pharmacology
  • Granulocyte Colony-Stimulating Factor / pharmacology
  • Hematopoietic Stem Cells / drug effects*
  • Hematopoietic Stem Cells / pathology
  • Humans
  • Interferon-gamma / pharmacology
  • Interleukin-3 / pharmacology
  • Interleukin-6 / pharmacology
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / blood*
  • Recombinant Proteins / pharmacology

Substances

  • Cytokines
  • Interleukin-3
  • Interleukin-6
  • Recombinant Proteins
  • Erythropoietin
  • Granulocyte Colony-Stimulating Factor
  • Interferon-gamma